Squamous cell carcinoma in a psoriasis patient after multiple courses of phototherapy

Cover Page

Abstract


The authors present a clinical case study of squamous cell carcinoma in a psoriasis patient after 24 courses of phototherapy (22 courses of PUVA therapy and two courses of mid-wavelength ultraviolet therapy (311 nm)). The malignant neoplasm developed against the background of signs of a chronic photodamage of the skin: lentigo, actinic elastosis, diffuse hyperpigmentation, spotty skin pigmentation.

M. B. Zhilova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: noemail@neicon.ru

Russian Federation

V. A. Smolyannikova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru

Russian Federation

  1. Weinberg A.S., Ogle C.A., Shim E.K. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg 2007; 33: 885-899.
  2. Vulf K., Jhonson R., Sуurmond D. Fitzpatrick,s Color atlas of clinical dermatology. Moskva, 2007: 338.
  3. Zlokachestvennye novoobrazovaniya V Rossii v 2012 godu (zabolevaemost' i smertnost'). Pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoy. M., 2014: 4.
  4. Khismatullina Z.R. Neoplasms of the skin. Epidemiology, classification, diagnosis. Kreativnaya khirurgiya i onkologiya. 2010; 3: 69-73.
  5. Fitzpatrick,s Dermatology in General Medicine (Dermatologiya Fitspatrika v klinicheskoy praktike): Klaus Wolff, Lowell A. Goldsmith, Stephen I. Katz, Barbara A. Gilchrest, Amy S. Paller, David J. Leffell. In: Kubanovа A.A., Ivanov A.N., eds. BINOM; 2012; Vol. 2: 1124.
  6. Greinert R., Volkmer B., Henning S., Breitbart E.W., Greulich K.O., Cardoso M.C., Rapp A. UVA-induced DNA doublestrand breaks result from the repair of clustered oxidative DNA damages. Nucleic Acids Res 2012; 40: 10263-10273.
  7. Moyal D.D., Fourtanier A.M. Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings. J Am Acad Dermatol 2008; 58: 149-154.
  8. Bruynzeel I., Bergman W., Hartevelt H.M. et al. "High single-dose" European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 1991; 124: 49-55.
  9. Lindelo^f B., Sigurgeirsson B., Tegner E., Lar-koè O., Johannesson A. PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 1999; 141: 108-112. Литература
  10. Hannuksela-Svahn A., Pukkala E., Koulu L., Jans_en C.T., Karvonen J. Cancer incidence among Finnish psoriasis patients treated with 8- methoxypsoralen bath PUVA. J Am Acad Dermatol 1999; 1: 694-696.
  11. BruynzeelI I., Bergman W., Hartevelt H.M. et al. ‘High single-dose’ European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 1991; 124: 49-55.
  12. Stern R.S., Laird N., Melski J., Parrish J.A., Fitzpatrick T.B., Bleich H.L.Cutaneous squamouscell carcinoma in patients treated with PUVA. Engl J Med 1984; 310: 1156-1161.
  13. Stern R.S., Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Derma-tol1988; 91: 120-124.
  14. Stern R.S. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study. N Engl J Med 1990; 322: 1093-1097.
  15. Stern R.S., Lunder E.J. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. Archives Of Dermatology 1998 Dec; 134 (12): 1582-5.
  16. Stern R.S., Liebman E.J., Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of non-melanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst 1998; 90: 1278-1284.
  17. Stern R.S. PUVA Follow-Up Study. The risk of melanoma in association with long-term exposure to PUVA. J Am Acad Dermatol 2001; 44: 755-761.
  18. Stern R.S., Bagheri S., Nichols K. et al. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. J Am Acad Dermatol 2002; 47: 33-39.
  19. Chuang T.Y., Heinrich L.A., Schultz M.D. et al. PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol 1992; 26: 173-177.
  20. Berg D., Otley C.C. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17.
  21. Martorell-Calatayud A., Sanmartin Jimenez O., Cruz Mojarrieta J., Guillén Barona C. Cutaneous squamous cell carcinoma: defining the high-risk variant. Actas Dermosifiliogr. 2013; 104: 367-79.
  22. Mullen J.T., Feng L., Xing Y., Mansfield P.F., Gershenwald J.E., Lee J.E., Ross M.I., Cormier J.N. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006; 13: 902-9.
  23. Jennings L., Schmults C.D. Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol. 2010; 3: 39-4.
  24. Brash D.E. Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol 2006; 154 Suppl 1: 8-10.
  25. Ratushny V., Gober M.D., Hick R., Ridky T.W., Seykora J.T. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 2012; 122: 464-472.
  26. Bastiaens M.T., ter Huurne J.A., Kielich C., Gruis N.A., Westendorp R.G., Vermeer B.J., Bavinck J.N. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001; 68: 884-894.
  27. Pacifico A., Goldberg L.H., Peris K., Chimenti S., Leone G., Ananthaswamy H.N. Loss of CDKN2A and p14ARF expressionoccurs frequently in human nonmelanoma skin cancers. Br J Dermatol 2008; 158: 291-297.
  28. Wang N.J., Sanborn Z., Arnett K.L., Bayston L.J., Liao W., Proby C.M., Leigh I.M. Loss-of-func-tion mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci USA 2011; 108: 17761-17766.
  29. Parris C.N., Jezzard S., Silver A., MacKie R., McGregor J.M., Newbold R.F. Telomerase activity in melanoma and nonmelanoma skin cancer. Br J Cancer 1999; 79: 47-53.
  30. Feldman S.R., Fleischer A.B. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Cutis 2011; 87: 201-207.
  31. Bastiaens M.T., ter Huurne J.A., Kielich C., Gruis N.A., Westendorp R.G., Vermeer B.J., Bavinck J.N. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001; 68: 884-894.
  32. Mullen J.T., Feng L., Xing Y., Mansfield P.F., Gershenwald J.E., Lee J.E., Ross M.I., Cormier J.N. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006; 13: 902-9.
  33. Rowe D.E., Carroll R.J., Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992; 26: 976-90.
  34. Enoch S., Miller D.R., Price P.E., Harding K.G. Early diagnosis is vital in the management of squamous cell carcinomas associated with chronic non healing ulcers: a case series and review of the literature. Int Wound J. 2004; 1: 165-75.
  35. Shlyakhtunov E.A., Gidranovich A.V., Lud N.G., Lud L.N., Kozhar V.L., Prokoshin A.V. Skin cancer: state of the problem. Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta. 2014; 13 (3); 20-28.
  36. Gantsev Sh.Kh., Yusupov A.S. Squamous cell carcinoma of the skin. Prakticheskaya onkologiya 2012; 13 (2): 80-91
  37. Swanson N.A. Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol. 1983; 119: 761-73.
  38. Veness M.J., Ong C., Cakir B., Morgan G. Squamous cell carcinoma of the lip. Patterns of relapse and outcome: Reporting the Westmead Hospital experience, 1980-1997. Australas Radiol 2001; 45: 195-9.
  39. Willey A., Mehta S., Lee P.K. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg. 2010; 36: 652-8.
  40. LeBoeuf N.R., Schmults C.D. Update on the management of high-risk squamous cell carcinoma. Semin Cutan Med Surg. 2011; 30: 26-34.
  41. Lebwohl M., Swanson N., Anderson L.L., Melgaard A., Xu Z., Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012; 366: 1010-9.
  42. Gaffney D.C., Soyer H.P., Simpson F. The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug target. Australas J Dermatol 2014; 55: 24-34.
  43. Cassarino D.S., Derienzo D.P., Barr R.J. Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification-part one. J Cutan Pathol 2006; 33: 191-206.
  44. Johnson W.C., Helwig E.B. Adenoid squamous cell carcinoma (adenoacanthoma): a clinico-pathologic study of 155 patients. Cancer 1966; 19: 1639-1650.
  45. Nappi O., Pettinato G., Wick M.R. Adenoid (acantholytic) squamous cell carcinoma of the skin. J Cutan Pathol. 1989; 16: 114-121.
  46. Schornagel J.H., Verweij J., de Mulder P.H., Cognetti F. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study. J Clin Oncol 1995 Jul; 13 (7): 1649-55.
  47. Katz K.A., Marcil I., Stern R.S. et al. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen+ ultraviolet a light-treated psoriasis patients. J Invest Dermatol 2002; 118: 1038-1043.

Views

Abstract - 104

PDF (Russian) - 48

Refbacks

  • There are currently no refbacks.

Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies